Skip To Content
Volunteer Advocate

News

All media inquiries can be directed to mediarelations@cysticfibrosis.ca or by calling 1-800-378-2233.


Cystic Fibrosis Canada launches Elevate to ensure work is guided by people impacted by disease
September 30, 2021

Community consultation program will enable people impacted by cystic fibrosis to provide input, insights and perspectives

Read More
Quebec lists Trikafta for reimbursement, offering new hope for Quebecers living with Cystic fibrosis
September 29, 2021

Cystic Fibrosis Canada calls on remaining provinces to save lives and list Trikafta immediately

Read More
Cystic Fibrosis Canada applauds Ontario, Alberta, and Saskatchewan for listing Trikafta under public drug benefit programs
September 24, 2021

Cystic Fibrosis Canada applauds Ontario, Alberta, and Saskatchewan for listing Trikafta under public drug benefit programs 

Read More
Cystic Fibrosis Canada calls on provinces to list Trikafta immediately, as final recommendation from CADTH issued
September 17, 2021

Provinces pressed to save lives by following guidance from CF clinicians, and fund Trikafta now for all Canadians who can benefit

Read More
Letter to the Honourable François Legault and Christian Dube
September 9, 2021

A letter has been sent to the Honourable François Legault, Premier of the Province of Quebec, and Christian Dubé, Minister of Health, regarding the INESSS recommendation for the cystic fibrosis drug, Trikafta. 

Read More
INESSS IGNORES CLINICAL GUIDELINES AND ISSUES SHORT SIGHTED RECOMMENDATION FOR TRIKAFTA
September 2, 2021

Cystic Fibrosis Canada calls on Quebec Health Minister to save lives by instead following the guidelines developed by CF clinicians, and fund Trikafta now for all Quebecers who can benefit...

Read More
Kin Canada reaches record-breaking $50 million in cumulative donations to Cystic Fibrosis Canada
August 21, 2021

Fundraising milestone a reflection of Kin Canada club members’ decades long commitment to the CF community.

Read More
Cystic Fibrosis Canada calls on provinces to use newest Standards of Care Guidelines and enable urgent access to the life-changing drug, Trikafta
August 17, 2021

 Cystic Fibrosis Canada has published new standardized care guidelines for modulator use in Canada.

Read More
CF Clinicians Speak Out Against Government Recommendations That Could Restrict Access to Miracle Drug Trikafta
August 12, 2021

If implemented, CADTH’s recommendation for the public funding of Trikafta would see access limited to only some of those who could benefit, requiring people to become sicker before offering treatment.

Read More
CADTH FAILS TO FULLY RECOGNIZE GREATEST INNOVATION IN CYSTIC FIBROSIS HISTORY
July 9, 2021

The Canadian Agency for Drugs and Technologies in Health (CADTH) provided this week short sighted and narrow guidance regarding game changing cystic fibrosis (CF) drug Trikafta, that, if adopted by the provinces, could effectively exclude over 25% of eligible Canadians with cystic fibrosis (CF), many of whom are youth, who could greatly benefit from the drug.

Read More